Neuropathic pain correlates with myelinated fibre loss and cytokine profile in POEMS syndrome

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 10, 2008, Pages 1171-1179

  Koike, H ^a   Iijima, M ^a   Mori, K ^a   Yamamoto, M ^a,b   Hattori, N ^a   Watanabe, H ^a   Tanaka, F ^a   Doyu, M ^c   Sobue, G ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL POPULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMYELINATION; ELECTROPHYSIOLOGY; ENDOCRINE DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERALGESIA; LEG PAIN; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MYELINATED NERVE; NERVE FIBER; NERVE POTENTIAL; NEUROPATHIC PAIN; POEMS SYNDROME; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSORY NERVE; SKIN; SURAL NERVE;

ADULT; AGED; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE FIBERS, MYELINATED; NEURAL CONDUCTION; NEURALGIA; PAIN MEASUREMENT; PERIPHERAL NERVES; POEMS SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 53149136215     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.135681     Document Type: Article

References (41)

1. Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 1984;34:712-20.
2. Kelly JJ Jr, Kyle RA, Miles JM, et al. Osteosclerotic myeloma and peripheral neuropathy. Neurology 1983;33:202-10.
3. Gherardi RK, Belec L, Soubrier M, et al. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood 1996;87:1458-65.
4. Watanabe O, Arimura K, Kitajima I, et al. Greatly raised vascular endothelial growth fasctor (VEGF) in POEMS syndrome. Lancet 1996;347:702.
5. Scarlato M, Previtali SC, Carpo M, et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain 2005;128:1911-20.
6. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood 2003;101:2496-506.
7. Kelly JJ Jr, Kyle RA, Miles JM, et al. The spectrum of peripheral neuropathy in myeloma. Neurology 1981;31:24-31.
8. Sobue G, Doyu M, Watanabe M, et al. Extensive demyelinating changes in the peripheral nerves of Crow-Fukase syndrome: a pathological study of one autopsied case. Acta Neuropathol 1992;84:171-7.
9. Dispenzieri A. POEMS Syndrome. Hematology (Am Soc Hematol Educ Program) 2005:360-7.
10. Dispenzieri A, Klein CJ, Mauermann ML. Lenalidomide therapy in a patient with POEMS syndrome. Blood 2007;110:1075-6.
11. Sinisakt M, Hietaharju A, Sauranen J, et al. Thalidomide in POEMS syndrome: case report. Am J Hematol 2004;76:66-8.
12. Badros A, Porter N, Zimrin A. Bevacizumab therapy for POEMS syndrome Blood 2005;106:1135.
13. Kuwabara S, Misawa S, Kanai K, et al. Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology 2006;66:105-7.
14. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-7.
15. Sobue G, Hashizume Y, Mukai E, et al. X-linked recessive bulbospinal neuronopathy, a clinicopathological study. Brain 1989;112:209-32.
16. Koike H, Iijima M, Sugiura M, et al. Alcoholic neuropathy is clinicopahthologically distinct from thiamine-deficiency neuropathy. Ann Neurol 2003;54:19-29.
17. Koike H, Iijima M, Mori K, et al. Nonmyelinating Schwann cell involvement with wellpreserved unmyelinated axons in CMTIA. J Neumpathol Exp Neurol 2007;66:1027-36.
18. Koike H, Mori K, Misu K, et al. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology 2001;56:1727-32.
19. Dyck PJ, Giannini C, Lais A. Pathologic alterations of nerves. In. Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral Neuropathy. 3rd ed. Philadelphia: W. B. Saunders, 1993:514-95.
20. Koike H, Misu K, Sugiura M, et al. Pathologic difference of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 2004;63:129-38.
21. Behse F, Buchthal F, Carlsen F, et al. Unmyelinated fibres and Schwann cells of sural nerve in neuropathy. Brain 1975;98:493-510.
22. Kanda T, Tsukagoshi H, Oda M, ef al. Morphological changes in unmyelinated nerve fibres in the sural nerve with age. Brain 1991:114:585-99.
23. Schröder JM, Gibbels E. Unmyelinated nerve fibers in senile nerves and in late thalidomide neuropathy: a quantitative electron microscopic study. Acta Neuropathol 1977;39:271-80.
24. Vital C, Gherardi R, Vital A, et al. Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes syndrome, ultrastructural study of peripheral nerve biopsy from 22 patients. Acta Neuropathol 1994;87:302-7.
25. Boukhris S, Magy L. Khali M, et al. Pain as the presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). J Neurol Sci 2007;254:33-8.
26. Brown MJ, Martin JR, Asbury AK. Painful diabetic neuropathy: a morphometric study. Arch Neurol 1976;33:164-71.
27. Mori K, Iijima M, Koike H, et al. The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain 2005;128:2518-34.
28. Oki Y, Koike H, Iijima M, et al. Ataxic vs painful form of paraneoplastic sensory neuropathy. Neurology 2007;69:564-72.
29. Onishi A, Dyck PJ. Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns. Arch Neurol 1974;31:120-7.
30. Kortzenburg M, Lundberg LE, Torebjörk HE. Dynamic and static components of mechanical hyperalgesia in human hairy skin. Pain 1992;51:207-19.
31. Rowbotham MC, Yosipovitch G, Connolly MK, et al. Cutaneous innervation density in the allodynic form of postherpetic neuralgia. Neurobiol Dis 1996;3:205-14.
32. Maihofner C, Handwerker HO, Neundorfer B, et al. Mechanical hyperalgesia in complex regional pain syndrome: a role for TNF-alpha? Neurology 2005;65:311-3.
33. Orstavik K, Namer B, Schmidt R, et al. Abnormal function of C-fibers in patients with diabetic neuropathy. J Neurosci 2006;26:11287-94.
34. Torebjork HE, Lundberg LE, LaMotte RH. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol 1992;448:765-80.
35. Bostock H, Campero M, Serra J, et al. Temperature-dependent double spikes in C-nociceptors of neuropathic pain patients. Brain 2005;128:2154-63.
36. Wasner G, Schattschneider J, Binder A, et al. Topical menthol-a human model for cold pain by activation and sensitization of C nociceptors. Brain 2004;127:1159-71.
37. Hitoshi S, Suzuki K, Sakuta M. Elevated serum interleukin-6 in POEMS syndrome reflects the activity of the disease. Intern Med 1994;33:583-7.
38. Saida K, Ohta M, Kawakami H, et al. Cytokines and myelin antibodies in Crow-Fukase syndrome. Muscle Nerve 1996;19:1620-2.
39. Lindenlaub T, Sommer C. Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol 2003;105:593-602.
40. Kitaoka Y, Kitaoka Y, Kwong JM, et al. TNF-alpha-induced optic nerve degeneration and nuclear factor-kappaB p65. Invest Ophthalmol Vis Sci 2006;47:1448-57.
41. Myers RR, Campana WM, Shubayev VI. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov Today 2006;11:8-20.